Each orodispersible tablet contains 10 mg of bilastine

Symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria. Drynolis indicated in children aged 6to 11 yearswith a body weight of at least 20 kg

Paediatric population-Children 6 to 11 years of age with a body weight of at least 20 kg 10 mg bilastine (1 orodispersible tablet) once daily for the relief of symptoms of allergic rhino-conjunctivitis (seasonal allergic rhinitis and perennial allergic rhinitis) and urticaria.The orodispersible tablet should be taken one hour before or two hours after intake of food orfruit juice